Srebp1 and its target genes including Fas, Acc, and Scd1 are up-regulated in NAFLD, and inhibiting Srebp1 activity impairs the induction of lipogenic Srebp1 target genes and TG accumulation (Bitter et al., 2015a, b). This evidence concerns the gene SCD and metabolic dysfunction-associated steatotic liver disease.